Cell & Gene Therapy
Enlivex receives approval for Phase I/II solid tumour trial in Israel
Nanoscope doses first subject in Phase II Stargardt disease trial
Arcellx shares Phase III CAR-T design plans in earlier line multiple myeloma
Innoskel enrols first patient to study collagen disorders in children
NIAID initiates Phase I trial of Moderna’s Nipah virus vaccine
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
